Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Indaptus Therapeutics Inc (NQ: INDP ) 1.450 -0.120 (-7.64%) Streaming Delayed Price Updated: 3:59 PM EDT, Sep 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Indaptus Therapeutics Inc < Previous 1 2 3 Next > INDP Stock Earnings: Indaptus Therapeutics Beats EPS for Q2 2024 August 12, 2024 INDP stock results show that Indaptus Therapeutics beat analyst estimates for earnings per share the second quarter of 2024. Via InvestorPlace 12 Health Care Stocks Moving In Friday's Pre-Market Session June 07, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session May 22, 2024 Via Benzinga INDP Stock Earnings: Indaptus Therapeutics Misses EPS for Q1 2024 May 08, 2024 INDP stock results show that Indaptus Therapeutics missed analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace 12 Health Care Stocks Moving In Thursday's After-Market Session May 02, 2024 Via Benzinga Indaptus Therapeutics: Q4 Earnings Insights March 13, 2024 Via Benzinga What 4 Analyst Ratings Have To Say About Indaptus Therapeutics May 04, 2023 Via Benzinga 12 Health Care Stocks Moving In Wednesday's After-Market Session May 01, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session April 05, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session March 11, 2024 Via Benzinga Why Okta Shares Are Trading Higher By Around 24%; Here Are 20 Stocks Moving Premarket February 29, 2024 Shares of Okta, Inc. (NASDAQ: OKTA) shares rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results and Via Benzinga Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session February 29, 2024 Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter financial results. Via Benzinga Around $15M Bet On Taysha Gene Therapies? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying August 17, 2023 The Dow Jones closed lower by around 180 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... Via Benzinga Topics Stocks Exposures US Equities Why Bluegreen Vacations Shares Are Trading Higher By Around 105%? Here Are Other Stocks Moving In Monday's Mid-Day Session November 06, 2023 Gainers Carbon Revolution Public Limited (NASDAQ: CREV) shares jumped 396.2% to $145.49 after gaining 100% on Friday. The company’s stock began trading on Friday following merger with Twin Ridge... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session May 10, 2023 Via Benzinga Indaptus Therapeutics Says Antitumor Platform Demonstrates Preclinical Efficacy Across Cancer Indications April 19, 2023 Indaptus Therapeutics Inc (NASDAQ: INDP) announces data presented in a poster at the American Association for Cancer Research (AACR) annual scientific conference on the company's Decoy anti-tumor... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session April 19, 2023 Via Benzinga Why Third Harmonic Bio Shares Are Trading Lower By Over 78%? Here Are 40 Stocks Moving In Thursday's Mid-Day Session December 15, 2022 Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) jumped 69.6% to $0.2604 after gaining 17% on Wednesday. Crown ElectroKinetics, last month, posted a Q3 loss of $0.18 per share. Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session December 13, 2022 Via Benzinga Indaptus Therapeutics: Q2 Earnings Insights August 08, 2022 Indaptus Therapeutics (NASDAQ:INDP) reported its Q2 earnings results on Monday, August 8, 2022 at 08:00 AM. Here's what investors need to know about the announcement. Via Benzinga Accolade Shares Jump Around 29%, Here's 75 Biggest Movers From Friday July 05, 2022 Gainers Omeros Corporation (NASDAQ: OMER) jumped 68.7% to close at $4.64. Clovis Oncology, Inc. (NASDAQ: CLVS) gained 58.3% to settle at $2.85 on Friday. Via Benzinga 66 Biggest Movers From Friday May 23, 2022 Gainers GeoVax Labs, Inc. (NASDAQ: GOVX) shares surged 90.2% to settle at $1.39 on Friday. GeoVax Labs, last month, said its Q1 sales results were lower year over year. Via Benzinga 38 Stocks Moving In Friday's Mid-Day Session May 20, 2022 Gainers Leju Holdings Limited (NYSE: LEJU) surged 27.8% to $4.0413. Via Benzinga 71 Biggest Movers From Yesterday May 20, 2022 Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares jumped 76.3% to close at $5.50 on Thursday after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation... Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session May 19, 2022 Gainers Radius Health (NASDAQ:RDUS) stock moved upwards by 18.8% to $6.94 during Thursday's after-market session. The company's market cap stands at $330.1 million. Via Benzinga 38 Stocks Moving In Thursday's Mid-Day Session May 19, 2022 Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares climbed 34.6% to $4.1993 after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation device as an aid for... Via Benzinga Why Is Indaptus Therapeutics (INDP) Stock Up 20% Today? May 19, 2022 Indaptus Therapeutics (INDP) stock is soaring higher on Thursday following an update from the U.S. Food and Drug Administration (FDA). Via InvestorPlace Indaptus Shares Jump On FDA Nod For Early-Stage Solid Tumor Trial May 19, 2022 The U.S. Food and Drug Administration (FDA) has announced clearance to Indaptus Therapeutics’ (NASDAQ: INDP) Investigational New Drug (IND) application for a Phase 1 clinical trial of its drug... Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session May 19, 2022 Via Benzinga Indaptus Therapeutics: Q1 Earnings Insights May 12, 2022 Indaptus Therapeutics (NASDAQ:INDP) reported its Q1 earnings results on Thursday, May 12, 2022 at 08:00 AM. Here's what investors need to know about the announcement. Via Benzinga < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.